Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Jane Montealegre Image

      Jane Montealegre

      Department of Behavioral Science, Division of Cancer Prevention and Population Sciences

      In the News

      Mailed self-collection HPV tests boost cervical cancer screening rates

      Present Title & Affiliation

      Dual/Joint/Adjunct Appointment

      Associate Professor, Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX

      Adjunct Associate Professor, Department of Pediatrics, Baylor College of Medicine, Houston, Texas

      Education & Training

      Degree-Granting Education

      2011The University of Texas School of Public Health, Houston, Texas, US, Epidemiology, Ph.D
      2005Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, US, Tropical Medicine, MSPH
      2004Tulane University, New Orleans, Louisiana, US, Ecology and Evolutionary Biology, BS

      Postgraduate Training

      2019-2019Traineeship, Training Institute in Dissemination and Implementation Science in Cancer, National Cancer Institute, Bethesda, Maryland
      2011-2013Postdoctoral Research Fellowship, Cancer Prevention, The University of Texas School of Public Health, Houston, Texas

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Department of Pediatrics-Hematology/Oncology, Baylor College of Medicine, Houston, TX, 2017 - 2023

      Instructor, Department of Pediatrics-Hematology/Oncology, Baylor College of Medicine, Houston, TX, 2014 - 2017

      Administrative Appointments/Responsibilities

      Interim Associate Director, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 2022 - 2023

      Assistant Director, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 2019 - 2023

      Deputy Director, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 2018 - 2023

      Senior Associate for Community Programs in Disparities, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 2014 - 2018

      Other Professional Positions

      Consultant, Global AIDS Program, U.S. Centers for Disease Control and Prevention-Guatemala, Guatemala City, Guatemala Department, 2010 - 2011

      Program Leader, Certification of Elimination of Oncocerciasis in the Santa Rosa Region, Guatemala, U.S. Centers for Disease Control and Prevention Medical Entomology Training Unit-G, Guatemala City, Guatemala Department, 2005 - Present

      Extramural Institutional Committee Activities

      Inaugural Vice Chair, National HPV Cancers Roundtable American Cancer Society, National HPV Cancers Roundtable American Cancer Society, 2026 - Present

      Member, American Association for Cancer Research (AACR) Cancer Epidemiology and Prevention Award Committee, The University of Texas MD Anderson Cancer Center, 2026 - 2028

      Advisory Board, Texas Lone Star Cervical Cancer Elimination Plan Cancer Alliance of Texas, Texas Lone Star Cervical Cancer Elimination Plan Cancer Alliance of Texas, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Cervical Cancer Elimination Advisory Board National Roundtable on Cervical Cancer American Cancer Society, National Roundtable on Cervical Cancer American Cancer Society, 2025 - Present

      Co-Chair, Transition Advisory Team,National Roundtable on Cervical Cancer and National HPV Roundtable, National Roundtable on Cervical Cancer and National HPV Roundtable, 2025 - Present

      Member, Practice, Implementation, and Equity Workgroup, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Population Science Working Group, American Association for Cancer Research, 2025 - Present

      Member, National Roundtable on Cervical Cancer Steering Committee American Cancer Society, American Cancer Society, 2025 - Present

      Member, CONNECT Texas Colorectal Cancer Screening Coordinating Center Steering Committee, The University of Texas-Austin, 2023 - Present

      Member, Self-Collection Workgroup, American Cancer Society, 2023 - Present

      Member, Cervical Cancer Screening Priority Area Workgroup, Cancer Alliance of Texas, 2020 - Present

      Chair, Commission on Cancer Standard 8.1 Workgroup: Addressing Barriers to Care, Harris Health System, 2016 - Present

      Editorial Activities

      Special Issue Guest Editor: Innovative and Impactful Strategies to Increase HPV Vaccine Delivery and Uptake, Vaccines, 2022 - 2023

      Honors & Awards

      2026 - PresentAmerican Cancer Society National Roundtable on Cervical Cancer Above and Beyond Award
      2026 - PresentAndrew Sabin Family Fellowship Award
      2025 - PresentFaculty Excellence in Community Outreach, MD Anderson Cancer Center
      20252026 Faculty Scholar Award, MD Anderson Cancer Center
      2024 - PresentWomen’s Health Award, Su Clinica, Brownsville, Texas
      2024Leading Mentor Award, MD Anderson Division of Cancer Prevention
      2023Invited panelist to the White House Gender Policy Council on Cervical Cancer Prevention, The White House Cancer Moonshot
      2022HPV Vaccine Champion Award, American Cancer Society-Texas
      2022Global Health Scholar, Baylor College of Medicine
      2021Young Investigator Award, Baylor College of Medicine, Department of Pediatrics
      2017Hearst Health Prize for Excellence in Population Health, The Hearst Foundation
      2009Student Field Activities Award, The University of Texas School of Public Health
      2009Dissertation Research Grant, U.S. Centers for Disease Control and Prevention
      2007 - 2009Public Health Traineeship, The University of Texas School of Public Health
      2004 - 2005Dean's Grant, Tulane University School of Public Health and Tropical Medicine
      2004Summa cum laude, Tulane University
      2004Fred P. Kagle Award for Outstanding Research in Biology, Tulane University
      2004Phi Kappa Phi, National Honors Society

      Professional Memberships

      American Society for Colposcopy and Cervical Pathology

      2025 - Present

      International Papillomavirus Society

      2016 - Present

      American Public Health Association

      2016 - 2018

      American Association of Cancer Research

      2012 - Present

      Selected Presentations & Talks

      Regional Presentations

      1. 2026. Cervical Cancer Screening Updates. Invited. Texas Association of Family Physicians Frank C. Webber Lectureship and Interim Session. Round Rock, Texas, US.
      2. 2026. Integrating HPV Self-Collection into Clinical Practice. Panelist. California Association of Public Health and American Cancer Society Cervical Cancer Screening Webinar. Virtual Meeting.
      3. 2025. Innovative Strategies to Increase Cancer Screening: Self-Collection for HPV Testing. Invited. Texas Association of Community Health Centers Annual Meeting. The Woodlands, Texas, US.
      4. 2025. Accelerating the Elimination of Cervical Cancer as a Public Health Problem. Invited. Grand Rounds, US.
      5. 2024. The Power of Elimination: Aligning Efforts to Achieve a Future Free of HPV Cancers in Texas (Keynote Presentation). Invited. Texas Human Papillomavirus Coalition Annual Meeting. Houston, Texas, US.
      6. 2022. Implementation of a Multi-Level Intervention to Increase Colorectal Cancer Screening and Follow-Up among the Medically Underserved. Invited. Southeastern Colorectal Cancer Consortium Annual Meeting. Irving, TX, US.
      7. 2022. A Multi-Level Intervention to Increase HPV Vaccination in a Safety Net Health System. Invited. Texas Immunization Conference, US.
      8. 2022. Communities in Action: HPV Vaccine Equity. Invited. American Cancer Society HPV Forum. Houston, TX, US.
      9. 2022. It Doesn’t Have to be so Hard: Cervical Cancer Screening in Underserved Populations. Invited. Prevention Grand Rounds. Houston, TX, US.
      10. 2021. Reasons for HPV Vaccine Missed Opportunities in a Safety Net Health System. Conference. National HPV Conference. Dallas, TX, US.
      11. 2013. HPV and Cervical Cancer Screening. Invited. Annual Cervical Cancer Summit, US.

      National Presentations

      1. 2026. The Urgency and Opportunity of Scaling Up Screening in Safety Net Health Systems. Invited. American Cancer Society Joint National Roundtables (Cervical Cancer and HPV) Meeting. Dallas, Texas, US.
      2. 2026. Updates in Cervical Cancer Screening: Expanding Options in the US through Self-Collection. Invited. American College of Obstetrics and Gynecology. Washington, D.C, District of Columbia, US.
      3. 2026. Implementation Science and Practice: Fundamentals for Clinicians. Panelist. American Society for Colposcopy and Cervical Pathology Annual Scientific Meeting. Orlando, Florida, US.
      4. 2026. HPV Self-Sampling in Safety Net and Low Resource Settings. Invited. American Association for Cancer Research Annual Meeting. San Diego, California, US.
      5. 2026. Reactions to a Positive HPV Test Following At-Home Self-Collection Among Underscreened Women in a U.S. Safety Net Health Setting: A qualitative Analysis. Conference. Eurogin World Congress. Vienna, Vienna, AT.
      6. 2026. Understanding Contextual Barriers and Facilitators to Future Implementation of a Novel Point-of-Care HPV DNA Test in Mozambique. Conference. Eurogin World Congress. Vienna, AT.
      7. 2025. Mailed Self-Collection for Cervical Cancer Screening Among Asian/Asian American Women in a Safety Net Setting. Conference. International Papillomavirus Conference. Bangkok, Bangkok, TH.
      8. 2025. Using Implementation Science to Accelerate Equity and the Elimination of Cervical Cancer. Invited. American Association for Colposcopy and Cervical Pathology Scientific Meeting. San Diego, CA, US.
      9. 2025. The Power of Connection. Panelist. Cervical Cancer Summit. Washington, DC, US.
      10. 2025. Elimination of HPV Cancers Beginning with Cervical: Perspectives from Texas. Invited. 2025 Virtual Annual Meeting of the HPV Vaccination Roundtable of the Southeast, US.
      11. 2025. HPV Self-Collection Testing for Cervical Cancer Screening. Invited. Delaware Cancer Consortium Meeting, Delaware, US.
      12. 2024. The Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Trial: Rationale, Design, and Preliminary Results. Invited. Medical University of South Carolina Hollings Cancer Institute, US.
      13. 2024. A Nuestro Alcance: Toward the elimination of cervical cacncer disparities among latinas. Invited. Latino Cancer Institute Seminar Series: Talking about cancer won't kill us, the silence will. Houston, Texas, US.
      14. 2024. Vacunacion Sin Barreras: School-Based HPV Vaccination in the Lower Rio Grande Valley of Texas. Invited. Empowering and Strengthening Community, Culture and Connection to Prevent HPV Cancers, US.
      15. 2024. Integrating Self-Collection in Safety Net Settings. Invited. National Roundtable on Cervical Cancer Annual Meeting. Atlanta, Georgia, US.
      16. 2024. Control and Elimination of HPV-Associated Cancers:A Future Within Our Reach. Invited. Rural HPV Vaccination Learning Community, US.
      17. 2024. Mailed at-home self-sampling for HPV testing increases screening participation among under-screened patients in a U.S. safety net health system: Results of the PRESTIS trial. Conference. American Association for Cancer Research Annual Meeting. San Diego, California, US.
      18. 2023. The Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Trial: Rationale, Design, and Preliminary Results. Invited. Tampa General Hospital Cancer Institute. Tampa, Florida, US.
      19. 2022. Self-Collection of HPV Testing to Expand Access to Cervical Cancer Screening. Invited. National Cancer Policy Panel: Advancing Progress in Cancer Prevention and Risk Reduction. Washington, DC, US.
      20. 2022. Using Self-Sample HPV Testing to Increase Cervical Cancer Screening in Safety Net Health Systems. Invited. American College of Epidemiology, ACE in Action Series, US.
      21. 2021. Adoption and Implementation of School-Based HPV Vaccination in the Lower Rio Grande Valley (RGV) of Texas, USA. Conference. American Society for Colposcopy and Cervical Pathology Scientific Meeting on Anogenital and HPV-Related Diseases, US.
      22. 2021. Using Every Chance You Get: Cancer Screening and Primary Prevention among Medically Underserved Populations. Invited. Georgetown University. Washington, DC, US.
      23. 2012. Respondent Driven Sampling for HIV Behavioral Surveillance among Immigrant Populations. Invited. University of Cincinnati. Cincinnati, OH, US.

      International Presentations

      1. 2026. Eurogin International Congress. Conference. Vienna, AT.
      2. 2025. International Papillomavirus Conference. Conference. International Papillomavirus Conference. Bangkok, TH.
      3. 2025. Barriers to cervical cancer screening and experiences with mailed self-collection kits for HPV testing among Asian/Asian American women in a U.S. safety net health system. Conference. Eurogin International Congress. Porto, PT.
      4. 2024. Predictors of Cervical Cancer Screening Uptake by Modality among Participants in the PRESTIS Trial to Assess Effectiveness of At-Home Self-Collection Kits for HPV Testing. Conference. International Papillomavirus Conference. Edinburgh, GB.
      5. 2023. Acceptability of Self-Sample HPV Testing among Underscreened Women in a Safety Net Health System. Conference. International Papillomavirus Conference. Washington, US.
      6. 2023. Perceived barriers to clinic-based cervical cancer screening and motivators for HPV self-sampling during the COVID-19 pandemic. Conference. Eurogin International Congress. Bilbao, ES.
      7. 2022. Impact of the COVID-19 Pandemic on Participation in a Self-Sample HPV Testing Randomized Trial. Conference. Eurogin International Congress. Dusseldorf, DE.
      8. 2022. Mailed, At-Home Self-Collection Kits to Increase Cervical Cancer Screening among Underscreened Patients in a Safety Net Health System: Results of the PRESTIS Trial. Conference. Eurogin International Congress. Stockholm, SE.
      9. 2022. Effectiveness-Implementation Research to Improve Cervical Cancer Screening (Estudio de efectividad- implementacion para mejorar tamizaje de cancer cervical). Invited. Mexican National Public Health Institute 100 Year Anniversary Series, US.
      10. 2021. HPV Vaccination In a Safety Net Health System During the COVID-19 Pandemic. Conference. Eurogin International Congress, US.
      11. 2021. Self-Sample HPV Testing to Increase Cervical Cancer Screening Participation. Invited. Preinvasive Disease Program, US.
      12. 2020. Self-Sample HPV Testing for Cervical Cancer Screening in Latin America and the Caribbean (La Auto-Toma de Muestras del VPH para el Tamizaje del Cáncer Cervico-Uterino en Latinoamérica y el Caribe). Invited. ECHO-Latin America (ELA) Program, US.
      13. 2011. Respondent Driven Sampling among Undocumented Central American Immigrant Women in Houston, Texas. Invited. Oslo, NO.

      Formal Peers

      1. 2025. Implementation Science.
      2. 2025. Introduction to Implementation Science and the Consolidated Framework for Implementation Research. Houston, Texas, US.
      3. 2024. Qualitative Research Methods. Lusaka, ZM.
      4. 2024. Fundamentos de la Autotoma(Fundamentals of Self-Collection). Visiting. Santiago, CL.
      5. 2023. Survey Research Methods. Lusaka, ZM.
      6. 2022. Faculty, Extension for Community Health Outcomes (ECHO)-Elimination of Cervical Cancer in Latin America (ECHO-ELA). Houston, Texas, US.
      7. 2022. Effectiveness-Implementation Research to Improve Cervical Cancer Screening (Estudio de efectividad- implementacion para mejorar tamizaje de cancer cervical). Invited. Mexico City, MX.
      8. 2021. Self-Sample HPV Testing to Increase Cervical Cancer Screening Participation. Invited, US.
      9. 2020. Self-Sample HPV Testing for Cervical Cancer Screening in Latin America and the Caribbean (La Auto-Toma de Muestras del VPH para el Tamizaje del Cáncer Cervico-Uterino en Latinoamérica y el Caribe). Invited, US.
      10. 2020. Self-Sample HPV Testing to Increase Cervical Cancer Screening Participation in Vulnerable Populations. Invited, US.
      11. 2011. Respondent Driven Sampling among Undocumented Central American Immigrant Women in Houston, Texas. Invited. Oslo, NO.
      Read More
      Less

      Grant & Contract Support

      Date: 2026 - 2031
      Title:Multidisciplinary Evaluation of Anal Cancer Screening in Women: MACS-W
      Funding Source:Medical University of South Carolina
      Role:Co-PI
      ID:FP00026597_Res1
      Date: 2026 - 2029
      Title:Disseminating a Multicomponent Intervention to Improve Cervical Cancer Screening and Follow-up
      Funding Source:The University of Texas at Austin/CANCER PREVENTION RESEARCH INST OF TX (CPRIT)
      Role:PI
      ID:FP00030389
      Date: 2026 - 2029
      Title:CATALYST: An Implementation Support Program to Increase Cervical Cancer Screening in Federally Qualified Health Centers
      Funding Source:CANCER PREVENTION RESEARCH INST OF TX
      Role:PI
      ID:PP270036
      Date: 2026 - 2031
      Title:Multidisciplinary Evaluation of Anal Cancer Screening in Women: MACS-W
      Funding Source:Medical University of Sourth Carolina, NIH
      Role:PI
      ID:R01CA313848
      Date: 2026 - 2030
      Title:Modeling Approaches to Improve Breast, Cervical, and Colorectal Cancer Screening Among Age-Eligible Women in the United States
      Funding Source:University of Texas at Austin
      Role:PI
      ID:FP00026709_Res2
      Date: 2026 - 2031
      Title:Evaluating a Multi-Specimen Random Access Point-of-Care Device for the Detection of HR-HPV: Diagnostic Performance and Impact on the Cervical Cancer Screening Cascade
      Funding Source:National Cancer Institute
      Role:Co-PI
      ID:1R01CA318401-01
      Date: 2026 - 2028
      Title:Co-Creating an Implementation Support Program to Accelerate the Adoption and Implementation of HPV Self-Collection for Cervical Cancer Screening in Safety Net Community Health Centers
      Funding Source:Andrew Sabin Family Fellows Program
      Role:PI
      ID:N/A
      Date: 2026 - 2031
      Title:Multidisciplinary Evaluation of Anal Cancer Screening in Women: MACS-W
      Funding Source:Medical University of South Carolina
      Role:Co-PI
      ID:FP00026597
      Date: 2026 - 2028
      Title:Primary HPV and HPV Self-Collection: ECHO-HPV-Screening, ECHO Scholars Program – 2026 Pilot Cohort
      Funding Source:The University of Texas MD Anderson Cancer Center
      Role:PI
      Date: 2025 - 2028
      Title:Self-collection, Capacity Building, and Resources to Enhance Cervical Cancer Screening and Navigation to Care for the Unhoused Population
      Funding Source:Cancer Prevention & Research Institute of Texas
      Role:Co-PI
      ID:PP260042
      Date: 2025 - 2028
      Title:Expanding Access to Cervical Cancer Screening through Primary HR-HPV Testing and Self-Sampling: A Multicomponent Intervention for Safety Net Health Systems
      Funding Source:BD Biosciences
      Role:PI
      ID:FP00027162
      Date: 2025 - 2030
      Title:UPR/MDACC: Partnership for Excellence in Cancer Research (Linked Application 1 of 2)
      Funding Source:NATIONAL INSTITUTES OF HEALTH
      Role:PI
      ID:2U54CA096300-21A1
      Date: 2024 - 2029
      Title:Implementing HPV Vaccination in HIV Treatment Settings (INVITE) For Young Women Living with HIV in Eswatini
      Funding Source:NIH/NCI
      Role:PI
      Date: 2024 - 2029
      Title:Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in Mozambique
      Funding Source:National Institutes of Health/National Cancer Institute
      Role:Co-PI
      ID:1U01CA292741-01
      Date: 2024 - 2029
      Title:Family Eats 2: Hybrid 1 Effectiveness-Implementation Trial
      Funding Source:NIH/NCI
      Role:Co-PI
      Date: 2024 - 2029
      Title:Implementing HPV Vaccination in HIV Treatment Settings (INVITE) for Young Women and Girls Living with HIV in Eswatini
      Funding Source:NIH/NCI
      Role:PI
      ID:1U01CA294753-01
      Date: 2024 - 2025
      Title:Understanding the impact of heterogeneity in psychosocial factors and social determinants of health on cancer treatment receipt among Zambia women diagnosed with cervical cancer
      Funding Source:NIH/NCI
      Role:PI
      ID:3R01CA28463-01
      Date: 2024 - 2029
      Title:Expanding Access to Cervical Cancer Screening through Primary HR-HPV Testing and Self-Sampling: A Multi-Component Intervention for Safety Net Health Systems
      Funding Source:Cancer Prevention & Research Institute of Texas
      Role:PI
      ID:PP240017
      Date: 2024 - 2028
      Title:Initiative for Innovation and Translation of Point-of-Care Technologies for Equitable Cancer Care in Texas (ITEX)- HPV POC
      Funding Source:William Marsh Rice University
      Role:Co-PI
      Date: 2023 - 2028
      Title:Family Eats 2: Hybrid 1 Effectiveness-Implementation Trial
      Funding Source:NIH/NCI
      Role:Co-PI
      Date: 2023 - 2024
      Title:Prevención en sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening in the Rio Grande Valley of Texas
      Funding Source:MD Anderson COE FUT
      Role:PI
      Date: 2022 - 2024
      Title:Expanding a pragmatic randomized trial to assess mailed self-sample HPV testing to increase cervical cancer screening participation among Asian immigrant women in a safety net health system
      Funding Source:NIH/NIMH
      Role:PI
      ID:3R01MD013715-04S2
      Date: 2022 - 2023
      Title:Enhancing Sexual Orientation and Gender Identity Data Collection across the Duncan Cancer Center - Administrative Supplement
      Funding Source:NIH/NCI
      Role:PI
      ID:P30 CA125123-16S1
      Date: 2022 - 2027
      Title:Advancing the Implementation of Evidence-Based Strategies for Tobacco Prevention and HPV Vaccination in Pediatric Safety Net Settings
      Funding Source:Cancer Prevention & Research Institute of Texas
      Role:PI
      ID:PP220038
      Date: 2022 - 2024
      Title:The Baylor College of Medicine-MD Anderson-Harris Health Cancer Patient Navigation (CANTO) Collaborative
      Funding Source:American Cancer Society
      Role:PI
      Date: 2022 - 2027
      Title:MD Anderson-Baylor College of Medicine-BU Research Base Consortium (MBRACE) toward Elimination of Cervical Cancer in Women Living with HIV
      Funding Source:NIH/NCI
      Role:Co-PI
      Date: 2022 - 2024
      Title:Examining Racial/Ethnic Differences and Determinants of Self-Sample HPV Testing and Usual Care Cervical Cancer Screening Uptake in a Safety Net Health System - Diversity Supplement to NIH/NIMHD
      Funding Source:NIH/NIMH
      Role:PI
      ID:3R01MD013715-04S1
      Date: 2021 - 2026
      Title:Strengthening Safety Net Health Systems to Improve Cervical and Colorectal Screening and Follow-Up among the Medically Underserved
      Funding Source:Cancer Prevention & Research Institute of Texas
      Role:Co-PI
      ID:PP210007
      Date: 2020 - 2022
      Title:Modifying the Home Environment to Promote and Support Child Obesity Prevention- Administrative Supplement to NCI P30 Cancer Center Support Grants to Support Community Outreach and Engagement (COE) Activities across the Translational Research Continuum
      Funding Source:NIH/NCI
      Role:PI
      ID:P30 CA125123-14S5
      Date: 2019 - 2022
      Title:Expanding a Community Network for Cancer Prevention to Increase HPV Vaccine Uptake and Tobacco Prevention in a Medically Underserved Pediatric Population
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:PI
      ID:PP190051
      Date: 2019 - 2026
      Title:A Randomized Controlled Trial of Mail-Self Stamped HPV Testing to Increase Cervical Cancer Screening Participation Among Minority/Underserved Women in an Integrated Safety Net Healthcare System
      Funding Source:National Institutes of Health/National Institute of Mental Health
      Role:PI
      ID:R01MD013715
      Date: 2017 - 2022
      Title:Expanding a Community Network for Cancer Prevention to Improve Cervical and Colorectal Screening and Follow-up Among an Urban Medically Underserved Population
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:PI
      ID:PP170094
      Date: 2016 - 2022
      Title:Leveraging a Community Network for Cancer Prevention to Increase HPV Vaccine Uptake and Completion among Pediatric Patients in a Safety Net Healthcare Setting
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:PI
      ID:P160079
      Date: 2009 - 2011
      Title:Sexual HIV Risk-Related Behaviors among Undocumented Central American Immigrant Women in Houston, Texas (Dissertation Research Grant)
      Funding Source:Centers for Disease Control (CDC)
      Role:PI
      ID:R36 PS001440-01

      Selected Publications

      Peer-Reviewed Articles

      1. Nogueras Gonzalez, G, Amboree, TL, Parker, SL, Bulsara, S, Deshmukh, AA, Daheri, ME, Hilsenbeck, SG, Adsul, P, Schmeler, KM, Scheurer, ME, Chiao, EY, Montealegre, JR. Barriers to cervical cancer screening and experiences using mailed at-home HPV self-collection kits among US and foreign-born Hispanic women in a safety net health system. Gynecologic oncology 211:238-245, 2026. e-Pub 2026. PMID: 42468446.
      2. Spencer, JC, Montealegre, JR, Calderon-Mora, J, Pignone, M. Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years. JAMA Network Open 9(5), 2026. e-Pub 2026. PMID: 42138919.
      3. Amboree, TL, Adsul, P, Damgacioglu, H, Schmeler, KM, Chiao, EY, Cruz, R, Sonawane, K, Deshmukh, AA, Montealegre, JR. National Outcomes of Increasing Cervical Cancer Screening in Federally Qualified Health Centers. JAMA Network Open 8(10), 2025. e-Pub 2025. PMID: 41123893.
      4. Tranh V, Spezia-Lindner N, Bilal M, Liu Y, Montealegre JR, Gould-Suarez M. Epidemiology of Early-onset Colorectal Cancer in a Safety-net Hospital System in Texas. J Clin Gastroenterol 59(9):869-869, 2025. e-Pub 2025.
      5. Montealegre JR, Hilsenbeck SG, Bulsara S, Parker SL, Amboree TL, Anderson ML, Daheri ML, Jibaja-Weiss ML, Schmeler KM, Deshmukh AA, Chiao EY, Scheurer ME. Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The PRESTIS Randomized Clinical Trial. JAMA Intern Med 185(9):1119-1127, 2025. e-Pub 2025. PMID: 40478588.
      6. Amboree TR, Montealegre JR, Damgacioglu H, Orr B, Wrangle J, Sonawane K, Deshmukh AA. County-level cervical cancer screening coverage and differences in incidence and mortality. JAMA Netw Open 8(8):e2526709, 2025. e-Pub 2025. PMID: 40802187.
      7. Parker, SL, Ayala-Ramirez, M, Montealegre, JR, Scheurer, ME. Implementing a stakeholder-informed approach for standardized collection of sexual orientation and gender identity data. Journal of the National Cancer Institute - Monographs 2025(69):134-138, 2025. e-Pub 2025. PMID: 40671548.
      8. Amboree TL, Damgacioglu H, Chiao EY, Schmeler KM, Sonawane K, Deshmukh AA, Montealegre JR. Rural-Urban Disparities in Cervical Cancer Incidence and Mortality Among US Women. JAMA Netw Open, 2025. e-Pub 2025. PMID: 40029664.
      9. Sokale, IO, Kuo, DC, Hoppenot, C, Reitzel, LR, Juarez, LH, Hernandez, KJ, Parker, SL, Amos, CI, Daheri, ME, Keene, KR, Montealegre, JR, Thrift, AP. Self-Collection for Primary HPV Testing: Acceptability in a Large Urban Emergency Department. Annals of emergency medicine 85(3):249-257, 2025. e-Pub 2025. PMID: 39545880.
      10. Sokale, IO, Montealegre, JR, Amuta, A, Oluyomi, AO, Thrift, AP. Racial and Ethnic Disparities in Human Papillomavirus Vaccination Among US-Born and Foreign-Born Adults Aged 18 to 26 Years in the United States. Vaccines 13(2), 2025. e-Pub 2025. PMID: 40006645.
      11. Amboree TL, Adsul P, Damgacioglu H, Schmeler KM, Chiao EY, Cruz R, Sonawane K, Deshmukh AA, Montealegre JR. National Outcomes of Increasing Cervical Cancer Screening in Federally Qualified Health Centers. JAMA Netw Open, 2024. e-Pub 2024. PMID: 41123893.
      12. Alvarez VHA, Amboree TL, Mitchell P, Badr HJ, Montealegre JR. Nativity Disparities in Colorectal Cancer Screening Among Hispanics in the United States. J Immigr Minor Health 26(4):632-640, 2024. e-Pub 2024. PMID: 38635108.
      13. Amboree, TL, Montealegre, JR, Parker, SL, Garg, A, Damgacioglu, H, Schmeler, KM, Chiao, EY, Hill, EG, Sonawane, K, Deshmukh, AA, Adsul, P. National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers. JAMA Internal Medicine 184(6):671-679, 2024. e-Pub 2024. PMID: 38683574.
      14. Hutcheson KA, Aldridge EF, Warneke CL, Buoy SN, Tang X, Macdonald C, Alvarez CP, Barringer DA, Barbon CE, Ebersole BM, McMillan H, Montealegre JR. Clinical Implementation of DIGEST as an Evidence- Based Practice Tool for Videofluoroscopy in Oncology: A Six- Year Single Institution Implementation Evaluation. Dysphagia 40(1):220-230, 2024. e-Pub 2024. PMID: 38935170.
      15. Amboree, TL, Damgacioglu, H, Sonawane, K, Adsul, P, Montealegre, JR, Deshmukh, AA. Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county-level income in the United States, 2000–2019. International Journal of Cancer 154(9):1549-1555, 2024. e-Pub 2024. PMID: 38270521.
      16. Parker SL, Amboree TL, Bulsara S, Daheri M, Anderson ML, Hilsenbeck SG, Jibaja-Weiss ML, Zare M, Schmeler KM, Deshmukh AA, Chiao EY, Scheurer ME, Montealegre JR. Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System. Am J Prev Med 66(3):540-547, 2024. e-Pub 2024. PMID: 37935320.
      17. Thompson, DI, Callender, C, Dave, JM, Jibaja-Weiss, M, Montealegre, JR. Health equity in action: Using community-engaged research to update an intervention promoting a healthy home food environment to Black/African American families. Cancer Causes and Control 35(2):311-321, 2024. e-Pub 2024. PMID: 37736870.
      18. Parker S, Deshmukh AA, Chen B, Lairson DR, Daheri M, Vernon SW, Montealegre JR. Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey. Elife 12, 2023. e-Pub 2023. PMID: 37232493.
      19. Amboree TL, Sonawane K, Deshmukh AA, Montealegre JR. Regular Healthcare Provider Status Does Not Moderate Racial/Ethnic Differences in Human Papillomavirus (HPV) and HPV Vaccine Knowledge. Vaccines (Basel) 9(7), 2021. e-Pub 2021. PMID: 34358219.
      20. Spezia-Lindner, NJ, Montealegre, JR, Daheri, ME, Harris, SL, Muldrew, KL, Suarez, MG. Use of fecal immunochemical testing in acute patient care in a safety net hospital system. Journal of Clinical Outcomes Management 28(2):82-89, 2021. e-Pub 2021.
      21. McGee LU, Ressler KS, Boom JA, Bulsara S, Sangi-Haghpeykar H, Jibaja-Weiss ML, Montealegre JR. Incomplete Records as a Leading Cause of Missed Opportunity for Human Papillomavirus Vaccine Initiation in a Safety Net Health System. Acad Pediatr 21(7):1118-1125, 2021. e-Pub 2021. PMID: 33359360.
      22. Montealegre JR, Anderson ML, Hilsenbeck SG, Chiao EY, Cantor SB, Parker SL, Daheri M, Bulsara S, Escobar B, Deshmukh AA, Jibaja-Weiss ML, Zare M, Scheurer ME. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial. Trials 21(1):872, 2020. e-Pub 2020. PMID: 33087164.
      23. Suk R, Montealegre JR, Nemutlu GS, Nyitray AG, Schmeler KM, Sonawane K, Deshmukh AA. Public Knowledge of Human Papillomavirus and Receipt of Vaccination Recommendations. JAMA Pediatr 173(11):1099-1102, 2019. e-Pub 2019. PMID: 31524931.
      24. Ho LH, JR M, Al-Arabi S, Jibaja-Weiss ML, Suarez MG. Impact of Colonoscopy Preparation Video on Boston Bowel Preparation Scale Score. Gastroenterol Nurs 42(3):251-258, 2019. e-Pub 2019. PMID: 31145249.
      25. Montealegre JR, Peckham-Gregory EC, Marquez-Do D, Dillon L, Guillaud M, Adler-Storthz K, Follen M, Scheurer ME. Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities. Gynecol Oncol 148(2):357-362, 2018. e-Pub 2018. PMID: 29276057.
      26. Kline KN, Montealegre JR, Rustveld LO, Glover TL, Chauca G, Reed BC, Jibaja-Weiss ML. Incorporating Cultural Sensitivity into Interactive Entertainment-Education for Diabetes Self-Management Designed for Hispanic Audiences. J Health Commun 21(6):658-68, 2016. e-Pub 2016. PMID: 27166651.
      27. Montealegre JR, Landgren RM, Anderson ML, Hoxhaj S, Williams S, Robinson DJ, Scheurer ME, Ramondetta LM. Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department. Gynecol Oncol 138(2):317-22, 2015. e-Pub 2015. PMID: 26026733.
      28. Montealegre JR, Mullen PD, L Jibaja-Weiss M, Vargas Mendez MM, Scheurer ME. Feasibility of Cervical Cancer Screening Utilizing Self-sample Human Papillomavirus Testing Among Mexican Immigrant Women in Harris County, Texas: A Pilot Study. J Immigr Minor Health 17(3):704-12, 2015. e-Pub 2015. PMID: 25358741.
      29. Montealegre JR, Gossey JT, Anderson ML, Chenier RS, Chauca G, Rustveld LO, Jibaja-Weiss ML. Implementing targeted cervical cancer screening videos at the point of care. Patient Educ Couns 97(3):426-9, 2014. e-Pub 2014. PMID: 25269411.
      30. Zhou R, JR M, Amirian ES, Scheurer ME. Reply to limitations in the imputation strategy to handle missing nativity data in the Surveillance, Epidemiology, and End Results program. Cancer 120(20):3262-3, 2014. e-Pub 2014. PMID: 24962422.
      31. Montealegre JR, Selwyn BJ. Healthcare coverage and use among undocumented Central American immigrant women in Houston, Texas. J Immigr Minor Health 16(2):204-10, 2014. e-Pub 2014. PMID: 23224739.
      32. Risser JM, Montealegre JR. Comparison of surveillance sample demographics over two cycles of the National HIV Behavioral Surveillance Project, Houston, Texas. AIDS Behav 18 Suppl 3:382-90, 2014. e-Pub 2014. PMID: 23907399.
      33. Whitehouse KC, Montealegre JR, Follen M, Scheurer ME, Aagaard K. Sociodemographic factors associated with pap test adherence and cervical dysplasia in surgically sterilized women. J Reprod Infertil 15(2):94-104, 2014. e-Pub 2014. PMID: 24918082.
      34. Montealegre JR, Zhou R, Amirian ES, Scheurer ME. Uncovering nativity disparities in cancer patterns: Multiple imputation strategy to handle missing nativity data in the Surveillance, Epidemiology, and End Results data file. Cancer 120(8):1203-11, 2014. e-Pub 2014. PMID: 24436157.
      35. Montealegre JR, Zhou R, Amirian ES, Follen M, Scheurer ME. Nativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of Surveillance, Epidemiology, and End Results data. Cancer Causes Control 24(11):1985-94, 2013. e-Pub 2013. PMID: 23934001.
      36. Montealegre JR, Johnston LG, Murrill C, Monterroso E. Respondent driven sampling for HIV biological and behavioral surveillance in Latin America and the Caribbean. AIDS Behav 17(7):2313-40, 2013. e-Pub 2013. PMID: 23568227.
      37. Montealegre JR, Follen M, Scheurer ME. Nativity differences in behaviors associated with high-risk HPV infection among Hispanic women in Houston, Texas, USA. J Immigr Minor Health 15(4):836-41, 2013. e-Pub 2013. PMID: 23300005.
      38. Montealegre JR, Risser JM, Selwyn BJ, McCurdy SA, Sabin K. Effectiveness of respondent driven sampling to recruit undocumented Central American immigrant women in Houston, Texas for an HIV behavioral survey. AIDS Behav 17(2):719-27, 2013. e-Pub 2013. PMID: 22961500.
      39. Montealegre JR, Risser JM, Selwyn BJ, McCurdy SA, Sabin K. Prevalence of HIV risk behaviors among undocumented Central American immigrant women in Houston, Texas. AIDS Behav 16(6):1641-8, 2012. e-Pub 2012. PMID: 22249955.
      40. Montealegre JR, Risser JM, Selwyn BJ, Sabin K, McCurdy SA. HIV testing behaviors among undocumented Central American immigrant women in Houston, Texas. J Immigr Minor Health 14(1):116-23, 2012. e-Pub 2012. PMID: 21964937.
      41. Montealegre JR, Koers EM, Bryson RS, Murray KO. An innovative public health preparedness training program for graduate students. Public Health Rep 126(3):441-6, 2011. e-Pub 2011. PMID: 21553674.
      42. Koers EM, Montealegre JR, Bryson RS, Murray KO. Experiences of the Student Epidemic Intelligence Society in strengthening public health response and epidemiologic capacity. Public Health Rep 125(6):922-8, 2010. e-Pub 2010. PMID: 21121239.
      43. Richards JE, Risser JM, Padgett PM, Rehman HU, Wolverton ML, Arafat RR. Condom use among high-risk heterosexual women with concurrent sexual partnerships, Houston, Texas, USA. Int J STD AIDS 19(11):768-71, 2008. e-Pub 2008. PMID: 18931271.

      Review Articles

      1. Spencer JC, Montealegre JR, Calderón-Mora J. Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years. JAMA Netw Open 9(5), 2026. e-Pub 2026.

      Abstracts

      1. Nogueras Gonzalez GM, Amboree TL, Parker S, Bulsara S, Deshmukh A, Daheri M, Hilsenbeck S, Adsul P, Schmeler KM, Scheurer ME, Chiao E, Montealegre J. Barriers to cervical cancer screening and experiences using mailed at-home HPV self-collection kits among US and foreign-born Hispanic women in a safety net health system 211(August 2026):238-245, 2026. e-Pub 2026.

      Letters to the Editor

      1. Fallah, PN, Montealegre, JR, Schmeler, KM, Salcedo, MP, Williams-Brown, Y. In Reply:. Obstetrics and gynecology 147: e39-e40, 2026.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 16, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top